Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Novel bioactive compounds from actinomycetes

J J Sanglier1, E M Wellington, V Behal

  • 1Sandoz Pharma Ltd., Basel, Switzerland.

Research in Microbiology
|October 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep learning assessment of metastatic relapse risk from digitized breast cancer histological slides.

Nature communications·2025
Same author

[Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis after SARS-CoV-2 infection: Fifteen-month follow-up].

Journal francais d'ophtalmologie·2024
Same author

Extra-mandibular Osteoradionecrosis after the Treatment of Head and Neck Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2023
Same author

Role of Adjuvant Radiotherapy in Acinic Cell Carcinoma of the Salivary Glands: A Systematic Review.

Clinical oncology (Royal College of Radiologists (Great Britain))·2023
Same author

The Impact of COVID-19 on Radiotherapy Services in Scotland, UK: A Population-based Study.

Clinical oncology (Royal College of Radiologists (Great Britain))·2022
Same author

The relationship between myocardial microstructure and strain in chronic infarction using cardiovascular magnetic resonance diffusion tensor imaging and feature tracking.

Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance·2022
Same journal

Deletion of major shell proteins of ethanolamine utilization microcompartment reduces intrinsic antibiotic resistance, biofilm, and intracellular survival of Salmonella Typhimurium.

Research in microbiology·2025
Same journal

Dynamic exometabolomics reveals metabolic adaptations of Staphylococcus epidermidis to pH-mimicking skin and bloodstream.

Research in microbiology·2025
Same journal

Co-expression network insights into Leptospira interrogans pathogenesis.

Research in microbiology·2025
Same journal

Differential DNA methylation associated with virulence attenuation in Edwardsiella piscicida.

Research in microbiology·2025
Same journal

Klebsiella pneumoniae-induced pneumonia: Pathogenesis, immune interactions, and antimicrobial resistance in a global context.

Research in microbiology·2025
Same journal

Investigating inhibitory effect of sterol targeting compounds against B. anthracis: Membrane microdomain a probable target.

Research in microbiology·2025
See all related articles

Actinomycetes bacteria are a rich source of novel antibiotics and enzymes. Researchers are discovering new compounds and enzyme activities from rare actinomycetes, showcasing their biotechnological potential.

Area of Science:

  • Microbiology
  • Biotechnology
  • Natural Product Chemistry

Background:

  • Actinomycetes are prolific producers of diverse secondary metabolites and enzymes.
  • Rare actinomycete strains, such as Spirillospora and Nocardioides, hold potential for discovering novel bioactive compounds.
  • Continuous discovery of new antibiotic classes, like polyenes, highlights ongoing research in this area.

Purpose of the Study:

  • To explore the potential of rare actinomycetes for novel compound and enzyme discovery.
  • To investigate the application of analytical techniques for identifying new actinomycete-derived molecules.
  • To characterize enzymatic activities from actinomycetes for biotechnological applications.

Main Methods:

  • Isolation and cultivation of rare actinomycete strains.

Related Experiment Videos

  • High-performance liquid chromatography coupled with a diode-array detector (HPLC-DAD) for compound analysis.
  • Biochemical assays for characterizing enzyme activities (amylolytic, lignolytic, peroxidase, neuramidase, cellulolytic).

    • Main Results:

    • Discovery of novel compounds from Spirillospora and Nocardioides strains.
    • Identification of new polyene antibiotics.
    • Characterization of various thermostable enzymes and isolation of novel cellulolytic actinomycetes.

    Conclusions:

    • Rare actinomycetes are a valuable resource for novel secondary metabolites, including antibiotics.
    • Advanced analytical methods aid in the discovery of new chemical entities.
    • Actinomycetes exhibit significant potential as industrial enzyme producers.